UK Regulator Advances AI Medical Device Sandbox Program

The UK's MHRA has initiated the third phase of its AI Airlock, an exploratory regulatory sandbox for AI-enabled medical devices. This multi-year funded program aims to deepen understanding of novel regulatory challenges and develop a suitable framework for these devices in Great Britain. It is significant for shaping future medical technology regulation and ensuring patient safety.